http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2364642-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed60a48f081c47fcb41e05e686144621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
filingDate 2001-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bb3aff7db1f509587bef61c967d9de3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad6b48c9452380f97bbd2cce27bec11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a367117f3ec40e81f3b05464c908e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d81671ecaef2dd108c1dd4f7667f24c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ae929d1c461651846883d9778b8a5f6
publicationDate 2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2364642-A
titleOfInvention Compositions for enhancing the immune response
abstract D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral administration of D-Ribose. Methods are also provided for the enhancement of the immune response in isolated leukocytes. Leukocytes are cultured <I>ex vivo</I> in the presence of D-Ribose and transfused into a patient in need of leukocyte augmentation.
priorityDate 2000-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6159942-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412563222

Total number of triples: 27.